UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Measurable residual disease monitoring provides insufficient lead-time to prevent morphologic relapse in the majority of patients with core-binding factor acute myeloid leukemia

Haematologica (Roma), 2021-01, Vol.106 (1), p.56-63

2021

Volltextzugriff (PDF)

Cancer patient perceptions on the ethical and legal issues related to biobanking

BMC medical genomics, 2013-03, Vol.6 (1), p.8-8, Article 8

2013

Volltextzugriff (PDF)

The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomes

Blood advances, 2018-10, Vol.2 (20), p.2658-2671

2018

Volltextzugriff (PDF)

A molecular compendium of genes expressed in multiple myeloma

Blood, 2002-09, Vol.100 (6), p.2175-2186

2002

Volltextzugriff (PDF)

Clinical and molecular correlates of JAK-inhibitor therapy failure in myelofibrosis: long-term data from a molecularly annotated cohort

Leukemia, 2022-06, Vol.36 (6), p.1689-1692

2022

Volltextzugriff (PDF)

Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents

Rheumatology (Oxford, England), 2010-11, Vol.49 (11), p.2172-2180

2010

Volltextzugriff (PDF)

The SH3-SAM adaptor HACS1 is up-regulated in B cell activation signaling cascades

The Journal of experimental medicine, 2004-09, Vol.200 (6), p.737-747

2004

Volltextzugriff (PDF)

The prevalence and accuracy of self-reported history of 11 autoimmune diseases

Journal of rheumatology, 2008-10, Vol.35 (10), p.2001

2008

Volltextzugriff (PDF)

P1040: FACTORS ASSOCIATED WITH THROMBOSIS IN MYELOFIBROSIS

HemaSphere, 2023-08, Vol.7 (S3), p.e91985c2-n/a

2023

Volltextzugriff (PDF)

MIP-1α (CCL3) is a downstream target of FGFR3 and RAS-MAPK signaling in multiple myeloma

Blood, 2006-11, Vol.108 (10), p.3465-3471

2006

Volltextzugriff (PDF)

Reduced proportions of natural killer T cells are present in the relatives of lupus patients and are associated with autoimmunity

Arthritis research & therapy, 2008-01, Vol.10 (5), p.R108-R108, Article R108

2008

Volltextzugriff (PDF)

Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia

Nature (London), 2014-02, Vol.506 (7488), p.328-333

2014

Volltextzugriff (PDF)

AKAP350, a Multiply Spliced Protein Kinase A-anchoring Protein Associated with Centrosomes

The Journal of biological chemistry, 1999-01, Vol.274 (5), p.3055-3066

1999

Volltextzugriff (PDF)

Soluble interleukin-13Rα2 decoy receptor inhibits Hodgkin's lymphoma growth in vitro and in vivo

Cancer research (Chicago, Ill.), 2004-05, Vol.64 (9), p.3271-3275

2004

Volltextzugriff (PDF)

HACS1 encodes a novel SH3-SAM adaptor protein differentially expressed in normal and malignant hematopoietic cells

Oncogene, 2001-08, Vol.20 (38), p.5373-5377

2001

Volltextzugriff (PDF)

Expression of schwannomin in lens and Schwann cells

Neuroreport, 1997-05, Vol.8 (8), p.2025-2030

1997

Volltextzugriff (PDF)

Stem Cell-Derived Gene Expression Scores Predict Survival and Leukemic Transformation in Myelofibrosis

Blood, 2022-11, Vol.140 (Supplement 1), p.9681-9682

2022

Volltextzugriff (PDF)

Inferior Outcomes with a High LSC17 Score Can be Improved with Flag-IDA

Blood, 2020-11, Vol.136 (Supplement 1), p.35-36

2020

Volltextzugriff (PDF)

Trial in Progress: Feasibility and Validation Study of the LSC17 Score in Acute Myeloid Leukemia Patients

Blood, 2019-11, Vol.134 (Supplement_1), p.2682-2682

2019

Volltextzugriff (PDF)

Widespread but cell type-specific expression of the mouse neurofibromatosis type 2 gene

Neuroreport, 1995-10, Vol.6 (14), p.1942-1946

1995

Volltextzugriff (PDF)

Impact of Genomic Alterations on Outcomes in Myelofibrosis Patients Undergoing JAK1/2 Inhibitor Therapy

Blood, 2016-12, Vol.128 (22), p.4263-4263

2016

Volltextzugriff (PDF)

Insights from the gene expression profiling of multiple myeloma

Current hematology reports, 2004-01, Vol.3 (1), p.67

2004

Volltextzugriff (PDF)

Advances in myeloma genetics and prospects for pharmacogenomic testing in multiple myeloma

American journal of pharmacogenomics, 2005, Vol.5 (1), p.35-43

2005

Volltextzugriff (PDF)

Stem cell tourism and Canadian family physicians

Canadian family physician, 2012-04, Vol.58 (4), p.365-368

2012

Volltextzugriff (PDF)

Cloning and Expression Analysis of a Novel WD Repeat Gene, WDR3, Mapping to 1p12–p13

Genomics (San Diego, Calif.), 1999-07, Vol.59 (1), p.85-89

1999

Volltextzugriff (PDF)

1 – 25 von 283

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(160)
Mit Volltextzugriff
(228)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Measurable residual disease monitoring provides insufficient lead-time to prevent morphologic relapse in the majority of patients with core-binding factor acute myeloid leukemia

Cancer patient perceptions on the ethical and legal issues related to biobanking

The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomes

A molecular compendium of genes expressed in multiple myeloma

Clinical and molecular correlates of JAK-inhibitor therapy failure in myelofibrosis: long-term data from a molecularly annotated cohort

Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents

The SH3-SAM adaptor HACS1 is up-regulated in B cell activation signaling cascades

The prevalence and accuracy of self-reported history of 11 autoimmune diseases

P1040: FACTORS ASSOCIATED WITH THROMBOSIS IN MYELOFIBROSIS

MIP-1α (CCL3) is a downstream target of FGFR3 and RAS-MAPK signaling in multiple myeloma

Reduced proportions of natural killer T cells are present in the relatives of lupus patients and are associated with autoimmunity

Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia

AKAP350, a Multiply Spliced Protein Kinase A-anchoring Protein Associated with Centrosomes

Soluble interleukin-13Rα2 decoy receptor inhibits Hodgkin's lymphoma growth in vitro and in vivo

HACS1 encodes a novel SH3-SAM adaptor protein differentially expressed in normal and malignant hematopoietic cells

Expression of schwannomin in lens and Schwann cells

Stem Cell-Derived Gene Expression Scores Predict Survival and Leukemic Transformation in Myelofibrosis

Inferior Outcomes with a High LSC17 Score Can be Improved with Flag-IDA

Trial in Progress: Feasibility and Validation Study of the LSC17 Score in Acute Myeloid Leukemia Patients

Widespread but cell type-specific expression of the mouse neurofibromatosis type 2 gene

Impact of Genomic Alterations on Outcomes in Myelofibrosis Patients Undergoing JAK1/2 Inhibitor Therapy

Insights from the gene expression profiling of multiple myeloma

Advances in myeloma genetics and prospects for pharmacogenomic testing in multiple myeloma

Stem cell tourism and Canadian family physicians

Cloning and Expression Analysis of a Novel WD Repeat Gene, WDR3, Mapping to 1p12–p13

Suchergebnisse filtern